An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone posted that they’ve been using a weekly injectable medication since March and lost a lot of weight — from 190 to 116 pounds — and have been on a maintenance weekly dose of 1 mg for four months. They’re thinking about lowering the dose to 0.5 mg or 0.25 mg. They say they have PCOS (polycystic ovary syndrome) and also have “bed” (likely a typo — maybe meant “BPD” or “bad sleep” — it’s unclear). They had used Wegovy (a brand for the same kind of drug) before, and when they stopped it their PCOS symptoms came back. They’re asking whether they should stay on a weekly shot or switch to a monthly injection. The drugs they’re referring to are in a class of medicines that mimic a natural gut hormone that talks to the brain. The most familiar names you’ve probably heard are Ozempic and Wegovy; the active ingredient in those is semaglutide. In plain terms: these medicines make you feel less hungry and slow how fast your stomach empties, which can lead to eating less and losing weight. They’re injections, typically given once a week. Some other medications in related classes are given more or less often, but semaglutide is usually weekly. What we can say about the evidence: semaglutide and similar drugs have been tested in many studies of people with obesity or with related conditions like type 2 diabetes. Those trials show significant weight loss for many people when they take the drug regularly, and symptoms tied to excess weight or metabolic problems can improve. For PCOS specifically, smaller studies and patient reports suggest weight loss and improvements in things like menstrual regularity, insulin resistance, and androgen (male-hormone) related symptoms, but the research is less extensive than for diabetes and general obesity. Importantly, most benefits occur while people are taking the drug; stopping it often leads to weight regain and return of prior symptoms, which matches the person’s experience when they stopped Wegovy. What this means for a regular person: if someone has PCOS and benefits from weight loss — better periods, less facial hair, improved insulin — a weekly semaglutide shot can help. The decision about dose (1 mg vs 0.5 mg vs 0.25 mg) and frequency (weekly vs monthly) matters because the drug’s effects depend on steady levels in the body. Semaglutide is approved and commonly prescribed as a weekly injection; monthly dosing is not the standard for semaglutide and would likely be less effective unless you’re switching to a different formulation made for monthly use. Any change in dose or schedule should be done under a doctor’s guidance, ideally with a plan for lifestyle support (diet, activity) and monitoring. Caveats and risks: these medications can cause nausea, diarrhea, constipation, stomach pain, and less commonly more serious issues like pancreatitis. They can also affect blood sugar, so people with diabetes or on other blood-sugar medicines need close monitoring. For people who are pregnant or trying to get pregnant, or who have certain medical histories, these drugs may not be appropriate. The snippet is a single person’s report — anecdote — not a controlled trial, so it doesn’t prove what will happen for everyone. Finally, stopping the drug often lets weight and PCOS symptoms return, so long-term planning with a provider is important. Bottom line: weekly semaglutide-type treatments can help people with PCOS by promoting weight loss and improving symptoms, but benefits usually require ongoing treatment and medical supervision; don’t alter dose or frequency on your own.
Source: r/Peptides